Aarti Drugs gets nod to make investment in Pinnacle Life Science

07 Mar 2026 Evaluate

Aarti Drugs has received approval to make investment in equity shares of Pinnacle Life Science (Pinnacle), wholly owned subsidiary of the company, upto an aggregate value of Rs 10.00 crore, by way of subscription to the rights issue. The company is interested in proposed transaction only to the extent of its shareholding in the Pinnacle. The investment proceeds will be used by Pinnacle for financing the cost towards expansion/capex plan and other general corporate purpose. 

The Finance & Investment Committee of the company at its meeting held on March 07, 2026, has approved the same.

Aarti Drugs is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary - Pinnacle Life Science.

Aarti Drugs Share Price

356.85 -3.65 (-1.01%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×